1. Home
  2. AEON vs AQMS Comparison

AEON vs AQMS Comparison

Compare AEON & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AEON
  • AQMS
  • Stock Information
  • Founded
  • AEON N/A
  • AQMS 2014
  • Country
  • AEON United States
  • AQMS United States
  • Employees
  • AEON N/A
  • AQMS N/A
  • Industry
  • AEON Biotechnology: Pharmaceutical Preparations
  • AQMS Metal Fabrications
  • Sector
  • AEON Health Care
  • AQMS Industrials
  • Exchange
  • AEON Nasdaq
  • AQMS Nasdaq
  • Market Cap
  • AEON 21.6M
  • AQMS 17.8M
  • IPO Year
  • AEON N/A
  • AQMS 2015
  • Fundamental
  • Price
  • AEON $0.15
  • AQMS $1.98
  • Analyst Decision
  • AEON Strong Buy
  • AQMS Strong Buy
  • Analyst Count
  • AEON 1
  • AQMS 2
  • Target Price
  • AEON $5.00
  • AQMS $30.00
  • AVG Volume (30 Days)
  • AEON 45.9M
  • AQMS 371.2K
  • Earning Date
  • AEON 11-13-2024
  • AQMS 11-14-2024
  • Dividend Yield
  • AEON N/A
  • AQMS N/A
  • EPS Growth
  • AEON N/A
  • AQMS N/A
  • EPS
  • AEON 0.34
  • AQMS N/A
  • Revenue
  • AEON N/A
  • AQMS N/A
  • Revenue This Year
  • AEON N/A
  • AQMS N/A
  • Revenue Next Year
  • AEON N/A
  • AQMS N/A
  • P/E Ratio
  • AEON $0.45
  • AQMS N/A
  • Revenue Growth
  • AEON N/A
  • AQMS 525.00
  • 52 Week Low
  • AEON $0.10
  • AQMS $1.33
  • 52 Week High
  • AEON $17.17
  • AQMS $14.14
  • Technical
  • Relative Strength Index (RSI)
  • AEON 27.61
  • AQMS 41.02
  • Support Level
  • AEON $0.10
  • AQMS $1.92
  • Resistance Level
  • AEON $0.22
  • AQMS $2.14
  • Average True Range (ATR)
  • AEON 0.05
  • AQMS 0.28
  • MACD
  • AEON -0.02
  • AQMS -0.05
  • Stochastic Oscillator
  • AEON 10.04
  • AQMS 6.32

About AEON AEON Biopharma Inc.

AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.

About AQMS Aqua Metals Inc.

Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.

Share on Social Networks: